Use of ketamine in France: recent trends (2012-2013)
Memo, OFDT, 8 p.
June 2014
This memo produced by the OFDT's TREND (Emerging trends and new drugs) Unit focuses on ketamine, a veterinary and human anaesthetic. Some drug users seek its exhilarating, intoxicating and "numbing" effects at low doses, while a smaller fraction of users experiment with higher doses and experience hallucinations and mind-body dissociation. In 2012-2013, the TREND network sites reported a continued spread of ketamine use in both the alternative party scene (including other settings such as clubs and discotheques) and the urban setting (among marginalised users), owing to the improved image of this drug which subsequently allays fears.
Authors : Michel Gandilhon, Agnès Cadet-Taïrou, Magali Martinez
Download the PDF file (518 Ko)
Drugs in Europe
2021 EMCDDA European Drug Report
COVID-19
How is the COVID-19 pandemic affecting drug use, supply and services?
Drug use and harms
What are the health costs of drug use in Europe today?
Drug markets
What do the latest data tell us about drug production and trafficking trends?
These and other questions are explored in the 2021 European Drug Report, our annual overview of the drug situation in Europe.
The annual Statistical Bulletin contains the most recent available data on the drug situation in Europe provided by the Member States. These datasets underpin the analysis presented in the European Drug Report. All data may be viewed interactively on screen and downloaded in Excel format..
The European Union and the drug phenomenon
The European Union & the drug phenomenon : Frequently asked questions, joint publication between the EMCDDA and the European Commission, october 2010, 12 p.
